EUR 34.0
(1.49%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 2.21 EUR | 22.1% |
2022 | 1.81 EUR | 7.74% |
2021 | 1.68 EUR | 95.35% |
2020 | 0.86 EUR | 10.26% |
2019 | 0.78 EUR | 6.85% |
2018 | 0.73 EUR | 21.67% |
2017 | 0.60 EUR | 22.45% |
2016 | 0.49 EUR | 63.33% |
2015 | 0.30 EUR | 20.0% |
2014 | 0.25 EUR | -16.67% |
2013 | 0.30 EUR | 5655.56% |
2012 | -0.01 EUR | -101.64% |
2011 | 0.33 EUR | 3.13% |
2010 | 0.32 EUR | 190.91% |
2009 | 0.11 EUR | -74.42% |
2008 | 0.43 EUR | 129.66% |
2007 | -1.45 EUR | 9.94% |
2006 | -1.61 EUR | -377.59% |
2005 | 0.58 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.68 EUR | -5.26% |
2024 Q1 | 0.76 EUR | 55.1% |
2023 Q3 | 0.29 EUR | -36.96% |
2023 Q2 | 0.46 EUR | -35.21% |
2023 Q1 | 0.71 EUR | 91.89% |
2023 Q4 | 0.49 EUR | 68.97% |
2023 FY | - EUR | 22.1% |
2022 Q2 | 0.20 EUR | -70.59% |
2022 FY | - EUR | 7.74% |
2022 Q4 | 0.37 EUR | 208.33% |
2022 Q3 | 0.12 EUR | -40.0% |
2022 Q1 | 0.68 EUR | 100.0% |
2021 Q1 | 0.48 EUR | 26.32% |
2021 FY | - EUR | 95.35% |
2021 Q4 | 0.34 EUR | 0.0% |
2021 Q3 | 0.34 EUR | -33.33% |
2021 Q2 | 0.51 EUR | 6.25% |
2020 Q4 | 0.38 EUR | 31.03% |
2020 Q2 | 0.06 EUR | -54.62% |
2020 FY | - EUR | 10.26% |
2020 Q3 | 0.29 EUR | 391.53% |
2020 Q1 | 0.13 EUR | -48.0% |
2019 Q3 | 0.09 EUR | -56.67% |
2019 Q1 | 0.22 EUR | -4.35% |
2019 Q2 | 0.21 EUR | -4.55% |
2019 Q4 | 0.25 EUR | 174.73% |
2019 FY | - EUR | 6.85% |
2018 Q1 | 0.24 EUR | 20.0% |
2018 Q3 | 0.07 EUR | -61.67% |
2018 FY | - EUR | 21.67% |
2018 Q4 | 0.23 EUR | 233.33% |
2018 Q2 | 0.18 EUR | -25.0% |
2017 Q2 | 0.14 EUR | -12.5% |
2017 FY | - EUR | 22.45% |
2017 Q4 | 0.20 EUR | 100.0% |
2017 Q3 | 0.10 EUR | -28.57% |
2017 Q1 | 0.16 EUR | 45.45% |
2016 Q1 | 0.18 EUR | 12.5% |
2016 FY | - EUR | 63.33% |
2016 Q4 | 0.11 EUR | 96.43% |
2016 Q3 | 0.06 EUR | -60.0% |
2016 Q2 | 0.14 EUR | -22.22% |
2015 Q4 | 0.16 EUR | 700.0% |
2015 Q1 | 0.09 EUR | -28.25% |
2015 Q2 | 0.04 EUR | -57.03% |
2015 Q3 | 0.02 EUR | -45.95% |
2015 FY | - EUR | 20.0% |
2014 Q4 | 0.12 EUR | 1265.05% |
2014 Q2 | 0.02 EUR | -85.83% |
2014 Q1 | 0.12 EUR | 34.83% |
2014 FY | - EUR | -16.67% |
2014 Q3 | -0.01 EUR | -160.59% |
2013 Q1 | 0.11 EUR | 216.53% |
2013 Q3 | -0.01 EUR | -107.91% |
2013 Q4 | 0.09 EUR | 1122.99% |
2013 FY | - EUR | 5655.56% |
2013 Q2 | 0.11 EUR | 0.0% |
2012 Q2 | 0.03 EUR | -61.45% |
2012 Q3 | -0.03 EUR | -180.63% |
2012 FY | - EUR | -101.64% |
2012 Q1 | 0.08 EUR | 0.0% |
2012 Q4 | -0.09 EUR | -265.89% |
2011 FY | - EUR | 3.13% |
2010 FY | - EUR | 190.91% |
2009 FY | - EUR | -74.42% |
2008 FY | - EUR | 129.66% |
2007 FY | - EUR | 9.94% |
2006 FY | - EUR | -377.59% |
2005 FY | - EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Pangaea Oncology, S.A. | -0.15 EUR | 1573.333% |